Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study by Solomon, Benjamin J, Prof, Besse, Benjamin, Prof, Bauer, Todd M, MD, Felip, Enriqueta, MD, Soo, Ross A, MD, Camidge, D Ross, Prof, Chiari, Rita, MD, Bearz, Alessandra, MD, Lin, Chia-Chi, MD, Gadgeel, Shirish M, Prof, Riely, Gregory J, MD, Tan, Eng Huat, MBBS, Seto, Takashi, Prof, James, Leonard P, MD, Clancy, Jill S, BS, Abbattista, Antonello, BSc, Martini, Jean-François, PhD, Chen, Joseph, PharmD, Peltz, Gerson, MD, Thurm, Holger, MD, Ou, Sai-Hong Ignatius, Prof, Shaw, Alice T, Prof

Get full text

Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1–2 trial by Shaw, Alice T, Prof, Solomon, Benjamin J, Prof, Chiari, Rita, MD, Riely, Gregory J, MD, Besse, Benjamin, Prof, Soo, Ross A, MD, Kao, Steven, MBChB, Lin, Chia-Chi, MD, Bauer, Todd M, MD, Clancy, Jill S, BS, Thurm, Holger, MD, Martini, Jean-Francois, PhD, Peltz, Gerson, MD, Abbattista, Antonello, BSc, Li, Sherry, MS, Ou, Sai-Hong Ignatius, Prof

Get full text

Association between environmental tobacco smoke exposure and the occurrence of EGFR mutations and ALK -rearrangements in never-smokers with non-small cell lung cancer: analyses fro... by Soo, Ross A., MD, Kubo, Akihito, MD PhD, Ando, Masahiko, MD PhD, Kawaguchi, Tomoya, MD PhD, Ahn, Myung-Ju, MD PhD, Ou, Sai-Hong Ignatius, MD PhD

Get full text

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study by Schuler, Martin, Prof, Cho, Byoung Chul, MD, Sayehli, Cyrus Michael, MD, Navarro, Alejandro, MD, Soo, Ross A, MBBS, Richly, Heike, MD, Cassier, Philippe Alexandre, MD, Tai, David, MBBS, Penel, Nicolas, MD, Nogova, Lucia, MD, Park, Se Hoon, MD, Schostak, Martin, MD, Gajate, Pablo, MD, Cathomas, Richard, MD, Rajagopalan, Prabhu, PhD, Grevel, Joachim, PhD, Bender, Sebastian, PhD, Boix, Oliver, PhD, Nogai, Hendrik, MD, Ocker, Matthias, MD, Ellinghaus, Peter, PhD, Joerger, Markus, MD

Get full text

Asian Subgroup Analysis of the Randomized Phase 3 CROWN Study of First-Line Lorlatinib Versus Crizotinib in Advanced ALK-Positive NSCLC by Zhou, Qing, XX, Soo, Ross A., XX, Chang, Gee-Chen, XX, Chiu, Chao-Hua, XX, Hayashi, Hidetoshi, XX, Kim, Sang-We, XX, Teraoka, Shunsuke, XX, Goto, Yasushi, XX, Zhou, Jianying, XX, Ho-Fun Lee, Victor, XX, Kim, Dong-Wan, XX, Han, Baohui, XX, Chung Man Ho, James, XX, Lin, Chia-Chi, XX, Lu, Shun, XX, Polli, Anna, XX, Calella, Anna Maria, XX, Martini, Jean-François, XX, Wong, Chew Hooi, XX, Mok, Tony, XX, Kim, Hye Ryun, XX, Wu, Yi-Long, MD

Get full text

Efficacy and Safety of S-1 Compared With Docetaxel in Elderly Patients With Advanced NSCLC Previously Treated With Platinum-Based Chemotherapy: A Subgroup Analysis of the EAST-LC T... by Chih-Hsin Yang, James, MD, PhD, Mok, Tony S.K., MD, Lu, Shun, MD, Nakagawa, Kazuhiko, MD, PhD, Yamamoto, Nobuyuki, MD, Shi, Yuan-Kai, MD, Zhang, Li, MD, Soo, Ross A., M.B.B.S., PhD, Morita, Satoshi, PhD, Tamura, Tomohide, MD

Get full text

Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC by Liao, Bin-Chi, Hsu, Wei-Hsun, Lee, Jih-Hsiang, Yang, Ching-Yao, Tsai, Tzu-Hsiu, Liao, Wei-Yu, Ho, Chao-Chi, Lin, Chia-Chi, Shih, Jin-Yuan, Yu, Chong-Jen, Soo, Ross A., Yang, James Chih-Hsin

Get full text

Coprescription of mood stabilizers in schizophrenia, dosing, and clinical correlates: An international study by Lim, Wai Kwong, Chew, Qian Hui, He, Yan‐Ling, Si, Tian‐Mei, Chiu, Fung‐Kum Helen, Xiang, Yu‐Tao, Kato, Takahiro A., Kanba, Shigenobu, Shinfuku, Naotaka, Lee, Min‐Soo, Park, Seon‐Cheol, Park, Yong‐Chon, Chong, Mian‐Yoon, Lin, Shih‐Ku, Yang, Shu‐Yu, Tripathi, Adarsh, Avasthi, Ajit, Grover, Sandeep, Kallivayalil, Roy Abraham, Udomratn, Pichet, Chee, Kok Yoon, Tanra, Andi J., Rabbani, Md Golam, Javed, Afzal, Kathiarachchi, Samudra, Waas, Dulshika, Myint, Wing Aung, Sartorius, Norman, Tran, Van Cuong, Nguyen, Kim Viet, Tan, Chay‐Hoon, Baldessarini, Ross J., Sim, Kang

Get full text

First-line systemic treatment of advanced stage non-small-cell lung cancer in Asia: consensus statement from the Asian Oncology Summit 2009 by Soo, Ross A, Dr, Anderson, Benjamin O, Prof, Cho, Byoung Chul, MD, Yang, Chih-Hsin, Prof, Liao, Meilin, Prof, Lim, Wan-Teck, MB, Goldstraw, Peter, Prof, Mok, Tony S, Prof

Get full text

The prevalence of expression of MAGE-A3 and PRAME tumor antigens in East and South East Asian non-small cell lung cancer patients by Thongprasert, Sumitra, Yang, Pan-Chyr, MD,PhD, Lee, Jung Shin, Soo, Ross, Gruselle, Olivier, Myo, Aung, Louahed, Jamila, Lehmann, Frédéric F, Brichard, Vincent G, Coche, Thierry

Get full text